Latest Issue of Science News


Feature

No New Meds

With drug firms in retreat, the pipeline for new psychiatric medications dries up

By
11:38am, February 7, 2013

Psychiatry seemed poised on the edge of a breakthrough. In early 2011, after decades of no radically new drugs, a fundamentally different schizophrenia treatment promised relief from the psychotic hallucinations and delusions plaguing people with the disease. The new compound, devised by chemists at Eli Lilly and Co., hit a target in the brain that older medicines had ignored.

This article is available only to subscribing members. Join SSP today or Log in.

More from Science News